SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended ...

Gastrointestinal (GI) Cancers Symposium, Dani Castillo, MD, medical oncologist, City of Hope, shared new research titled, “Impact of metastatic sites and Lauren subtype on survival outcomes of ...

Yuman Fong, MD, discusses the evolution of colorectal liver metastases management from historical neglect to multimodal ...

A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...

This review highlights the potential of natural polysaccharide microneedles in cancer immunotherapy, focusing on localized ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.

Liver disease is a major global health problem, causing over two million deaths worldwide each year. While animal models have helped to understand liver biology, they often fail to accurately ...

The MarketWatch News Department was not involved in the creation of this content. -- Wegovy(R) (semaglutide injection) granted conditional marketing authorization for the treatment of non-cirrhotic ...

Ovarian cancer is dangerous and difficult to treat, partly because it’s hard to diagnose early, and partly because it’s often resistant to existing drugs. Now scientists looking for new treatments ...